[go: up one dir, main page]

AU2001242876A1 - Compositions suitable for the treatment of damage caused by ischemia/reperfusionor oxidative stress - Google Patents

Compositions suitable for the treatment of damage caused by ischemia/reperfusionor oxidative stress

Info

Publication number
AU2001242876A1
AU2001242876A1 AU2001242876A AU4287601A AU2001242876A1 AU 2001242876 A1 AU2001242876 A1 AU 2001242876A1 AU 2001242876 A AU2001242876 A AU 2001242876A AU 4287601 A AU4287601 A AU 4287601A AU 2001242876 A1 AU2001242876 A1 AU 2001242876A1
Authority
AU
Australia
Prior art keywords
ischemia
oxidative stress
damage caused
reperfusionor
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001242876A
Other languages
English (en)
Inventor
Zandrie Hofman
Hendrik Gerrit Derk Leuvenink
Eduard Christiaan Van Hoorn
Klaske Van Norren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of AU2001242876A1 publication Critical patent/AU2001242876A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/577Malvaceae (Mallow family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heat Treatment Of Articles (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
AU2001242876A 2000-03-22 2001-03-22 Compositions suitable for the treatment of damage caused by ischemia/reperfusionor oxidative stress Abandoned AU2001242876A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00201051A EP1136073A1 (de) 2000-03-22 2000-03-22 Zusammensetzungen zur Behandlung von Schäden verursacht durch Ischämie/Reperfusion oder oxidativem Stress
NL00201051.0 2000-03-22
PCT/NL2001/000233 WO2001070248A1 (en) 2000-03-22 2001-03-22 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress

Publications (1)

Publication Number Publication Date
AU2001242876A1 true AU2001242876A1 (en) 2001-10-03

Family

ID=8171244

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001242876A Abandoned AU2001242876A1 (en) 2000-03-22 2001-03-22 Compositions suitable for the treatment of damage caused by ischemia/reperfusionor oxidative stress

Country Status (9)

Country Link
US (2) US20040076692A1 (de)
EP (2) EP1136073A1 (de)
JP (1) JP2003527434A (de)
AT (1) ATE316382T1 (de)
AU (1) AU2001242876A1 (de)
DE (1) DE60116860T2 (de)
DK (1) DK1267901T3 (de)
ES (1) ES2257401T3 (de)
WO (1) WO2001070248A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939115B2 (en) * 2000-06-12 2011-05-10 Access Business Group International Llc Dietary supplement and related method
US7416749B2 (en) * 2000-06-12 2008-08-26 Access Business Group International Llc Dietary supplement and related method
US7438936B2 (en) * 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
WO2003041703A2 (en) * 2001-11-16 2003-05-22 Gho Holding B.V. Use of a flavonoid for the treatment of burns
WO2004017997A1 (ja) * 2002-08-06 2004-03-04 Toray Industries, Inc. 腎疾患治療又は予防剤及び腎疾患の診断方法
DE10257360A1 (de) * 2002-12-09 2004-07-08 Fresenius Kabi Deutschland Gmbh Gastro-intestinal verabreichbare Formulierung und deren Verwendung
FR2854307A1 (fr) * 2003-04-30 2004-11-05 Jean Morelle Utilisation de complements vegetaux d'origine alimentaire, de proprietes anti-stress oxydatif dans le cadre de l'effort physique, humain ou animal
JP2005097222A (ja) * 2003-08-26 2005-04-14 Toyo Shinyaku:Kk タマネギ発酵物
BRPI0414501A (pt) * 2003-09-19 2006-11-07 Nutricia Nv usos de carboidratos digerìveis solúveis em água e de um componente aumentador de guanosina-5' -trifosfato (gtp) hepático e de carboidratos digerìveis solúveis em água e de peptìdeos com atividade inibitória de ace,e, composição aquosa lìquida adequada para administração enteral
US7384654B2 (en) 2004-02-05 2008-06-10 Access Business Group International Llc Anti-Allergy composition and related method
WO2007018687A1 (en) * 2005-07-21 2007-02-15 University Of Florida Research Foundation, Inc. Compositions and methods for treatment and prevention of hyperuricemia related health consequences
JP2008506785A (ja) 2004-07-21 2008-03-06 フロリダ大学 リサーチファウンデーション インコーポレイティッド インスリン抵抗性の治療及び予防のための組成物及び方法
CA2601028C (en) * 2005-03-11 2014-05-27 Howard Florey Institute Of Experimental Physiology And Medecine Flavonoid compounds and uses thereof
WO2009093584A1 (ja) * 2008-01-23 2009-07-30 Kaneka Corporation 植物由来の高尿酸血症の予防または改善剤
US8648059B2 (en) * 2008-03-13 2014-02-11 The Regents Of The University Of California Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling
CN102872124B (zh) * 2012-10-27 2013-10-23 南京大学 Houttuynoid A在预防或治疗胰腺纤维化的药物中的应用
CN102872127B (zh) * 2012-10-27 2013-07-17 吴俊华 Houttuynoid C在预防或治疗胰腺纤维化的药物中的应用
JP7401863B2 (ja) * 2020-10-08 2023-12-20 国立大学法人 鹿児島大学 血管攣縮抑制剤、血管攣縮予防剤、血管攣縮予防用経口組成物及び血管攣縮抑制用経口組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2903318B2 (ja) * 1989-04-04 1999-06-07 日研フード株式会社 抗酸化的ストレス物
FR2697159B1 (fr) * 1992-10-22 1995-01-13 Oreal Composition cosmétique ou dermo-pharmaceutique contenant en association un lauroylméthionate d'un amino acide basique et au moins un polyphénol.
FR2699818B1 (fr) * 1992-12-24 1995-02-03 Oreal Composition cosmétique ou pharmaceutique contenant en association un polyphénol et un extrait de gingko.
GB2290487B (en) * 1994-06-23 1998-06-10 John Hunter Dual fuel fluidised bed gasification-combustion system
DE4441279C1 (de) * 1994-11-19 1995-09-21 Abb Management Ag Vorrichtung zur Strombegrenzung
IT1286564B1 (it) * 1996-03-05 1998-07-15 Comiter Trading & Services S R Un prodotto a base di olio extravergine di oliva,olio vergine di oliva od olio di oliva arricchito ed integrato,ed un procedimento per
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US5886029A (en) * 1997-09-05 1999-03-23 Dhaliwal; Kirpal S. Method and composition for treatment of diabetes
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
ATE228011T1 (de) * 1998-08-06 2002-12-15 Vascular Biotech Gmbh Wirkstoffkombination insbesondere zur prophylaxe und therapie von ischämischen organschäden und reperfusionssyndromen
WO2000025795A1 (en) * 1998-10-29 2000-05-11 Merck Patent Gmbh Compositions comprising a mixture of bioflavonols
DE29908634U1 (de) * 1999-04-09 1999-12-16 Hoensch, Harald, Prof.Dr.med., 64521 Groß-Gerau Nahrungsergänzungsmittel zur Behandlung von Darmerkrankungen
EP1173069A1 (de) * 1999-04-26 2002-01-23 Imperial Sensus, L.L.C. Granuliertes verabreichungssystem
US6291533B1 (en) * 1999-12-22 2001-09-18 Vitamerica, Inc. Dietary supplements for each specific blood type

Also Published As

Publication number Publication date
HK1051503A1 (en) 2003-08-08
EP1136073A1 (de) 2001-09-26
ATE316382T1 (de) 2006-02-15
EP1267901A1 (de) 2003-01-02
US20060270615A1 (en) 2006-11-30
DE60116860D1 (de) 2006-04-13
EP1267901B1 (de) 2006-01-25
WO2001070248A1 (en) 2001-09-27
DK1267901T3 (da) 2006-05-29
ES2257401T3 (es) 2006-08-01
JP2003527434A (ja) 2003-09-16
US20040076692A1 (en) 2004-04-22
DE60116860T2 (de) 2006-09-21
EP1267901B9 (de) 2006-06-28

Similar Documents

Publication Publication Date Title
AU2001242876A1 (en) Compositions suitable for the treatment of damage caused by ischemia/reperfusionor oxidative stress
EP2255661A3 (de) Enteralformulierungen von Proanthocyanidin-Polymer-Zusammensetzungen gegen Diarrhöe
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
IL143332A0 (en) Scavenger compounds
AU5669298A (en) Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
YU23102A (sh) Jedinjenja za lečenje ishemije
AU4120699A (en) Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
AU4485093A (en) Cosmetic or pharmaceutical composition comprising, in combination, a peroxidase and an anti-singlet oxygen agent
NZ331104A (en) Phenyl thiazole derivatives that inhibit herpes replication by inhibiting the herpes helicase primase enzyme complex
WO1999043654A3 (en) Inhibitors of phospholipase enzymes
AU6783698A (en) Polyaromatic antiviral compositions
BR9908004A (pt) Composto, composição e método para prevençãoou supressão de uma infecção viral
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
CA2343236A1 (en) 4,4-biarylpiperidine derivatives
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
WO2001093909A3 (en) Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor
YU24402A (sh) 2'-supstituisani 1,1'-bifenil-2-karbonamidi, postupak za njihovu proizvodnju, njihova primena kao leka kao i farmaceutski preparati koji sadrže ta jedinjenja
GB2320431B (en) Compositions for the treatment of chronic wounds
AU2001230202A1 (en) Formulation for protection against oxidative stress containing benzofuranone derivatives
WO1997034599A3 (en) Use of clotrimazole and related compounds in the treatment of diarrhea
BR0210744A (pt) Combinação farmacêutica sinergìstica para a prevenção ou tratamento de diabetes
GR3036142T3 (en) Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
CA2189955A1 (en) Composition for the preservation of organic tissues
AU1816500A (en) Bleaching compositions